Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2026-02-23 @ 4:55 AM
Study NCT ID:
NCT05217693
Status:
RECRUITING
Last Update Posted:
2025-07-24
First Post:
2021-12-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors
Sponsor:
Bliss Biopharmaceutical (Hangzhou) Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BB-1705-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None